Duracef 500 mg hard capsules

Duracef is a pharmaceutical product containing cefadroxil, a first-generation cephalosporin antibiotic. Originally developed by Mead Johnson (which later became part of Bristol-Myers Squibb), the brand has seen various licensing and ownership changes across different global markets.

In the Spanish market, as seen on the packaging, the product is handled by Exeltis, a specialized pharmaceutical company. Manufacturing for these types of generic and legacy antibiotic brands often takes place in multiple specialized facilities across Europe and Asia to meet local regulatory requirements and supply chain demands. The current ownership of the brand name resides within the portfolio of the Insud Pharma group through its Exeltis division, which focuses on various therapeutic areas including women's health and dermatology.